{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid4lara7bcxfkmfryyis2mh4kgnc3hkfknsruzs5xxfwd5a2jgkoi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mir66to6gg32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia57rmpo7gqiyyqawkqttjtcqub5dinshqi4yq5ijkvkdhty2crc4"
    },
    "mimeType": "image/jpeg",
    "size": 966048
  },
  "path": "/news/2026-03-ai-tool-aggressive-small-cell.html",
  "publishedAt": "2026-04-05T11:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with extensive-stage small cell lung cancer will respond to platinum-based chemotherapy—before treatment has begun, and without additional biopsies. That means patients can avoid treatments that are unlikely to help them, have a chance to enroll earlier in clinical trials of newer drugs, and may get a clearer picture of their prognosis.",
  "title": "New AI tool predicts whether aggressive small cell lung cancer will respond to treatment"
}